Recently, the fifth Fudan Zhongshan Patent Salon with the theme of "Leading Originality, Empowering the Future" was held at Zhongshan Hospital Fudan University. Dunwill Medical and Zhongshan Hospital completed multiple annual major transformation project signing ceremonies, opening a new chapter of deep cooperation.

This salon brought together numerous medical elites and business representatives to jointly depict the grand blueprint of medical innovation. Zhou Jian, Dean of Zhongshan Hospital, introduced that the self-developed reagent project signed this time covers multiple disease fields such as cardiomyopathy, cholangiocarcinoma, gastric cancer, colon cancer, soft tissue tumors, endometrial cancer, primary aldosteronism, Marfan syndrome, etc. It adopts internationally leading detection technology to achieve multi-index joint detection, providing strong support for accurate diagnosis of diseases. These advanced in vitro diagnostic reagents, after transformation, will be rapidly applied in clinical practice, greatly improving the diagnostic level of diseases and bringing precise diagnosis and treatment services and better treatment outcomes to more patients.

As a globally leading research-based IVD company focused on the discovery, development, and commercialization of innovative original biomarker, Dunwill Medical leverages its advantages in empowering clinical translation and unique multi-platform integration capabilities. Starting from identifying clinical needs and pain points, Dunwill Medical collaborates with clinical experts to study the mechanisms of complex disease occurrence and development from a "temporal and spatial dimension", promoting the formation of multiple original clinical IVD products with independent intellectual property rights.

At the conference, Jusbio Sciences (Shanghai) Co., Ltd., a subsidiary of Dunwill Medical, held a signing ceremony with Zhongshan Hospital for the development project of multiple patents. Dr. Hou Ying, Executive Director of Dunwill Medical Market and Strategic Development Center, participated in the signing ceremony as a representative of the company.

Fan Jia, an academician of the CAS Member and honorary president of Zhongshan Hospital, said that as the first comprehensive national medical center in China, Zhongshan Hospital has always strongly encouraged medical personnel to actively carry out invention and creation in clinical work, and has spared no effort to cultivate "doctor inventors" and "doctor scientists", so as to inject continuous vitality into the vigorous development of medical cause.

With the gradual deepening of cooperation between both parties, Dunwill Medical's innovation and transformation capabilities will be closely integrated with the clinical practice of Zhongshan Hospital, and it is expected to achieve new breakthroughs. Dunwill Medical will continue to uphold the spirit of "forging ahead and constantly innovating", and contribute more to the progress of medical technology. In the future, we look forward to more innovative transformation achievements being implemented one by one, benefiting more patients in clinical diagnosis and treatment services.